Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2008-01-11 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BRIGNAIS (69530), Rhone
PHARMACIE DU GAREL : revenue, balance sheet and financial ratios
PHARMACIE DU GAREL is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BRIGNAIS (69530),
this company of category PME
shows in 2018 a revenue of 1.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU GAREL (SIREN 501983654)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
1 144 237 €
1 124 712 €
1 091 396 €
Net income
45 323 €
183 735 €
167 575 €
103 012 €
45 682 €
72 858 €
65 892 €
89 632 €
67 688 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
96 959 €
160 988 €
114 481 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
5.8%
8.0%
6.2%
Revenue and income statement
In 2024, PHARMACIE DU GAREL generates positive net income of 45 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 68 k€ -> 45 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
45 323 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 23%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 70%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
22.577%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
69.874%
Solvency indicators evolution PHARMACIE DU GAREL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
45.79
29.503
19.98
10.618
2.795
0.0
4.58
10.874
22.577
Financial autonomy
59.633
66.414
71.921
76.412
82.762
83.643
76.398
72.616
69.874
Repayment capacity
3.604
2.254
2.081
None
None
None
None
None
None
Cash flow / Revenue
6.809%
7.949%
6.109%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
22.582024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good
In 2024, the debt ratio of PHARMACIE DU GAREL (22.58) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
69.87%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent
In 2024, the financial autonomy of PHARMACIE DU GAREL (69.9%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU GAREL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
107 470 €
150 363 €
157 973 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
29
28
29
0
0
0
0
0
0
Customer payment term (days)
7
10
8
0
0
0
0
0
0
Supplier payment term (days)
47
49
47
0
0
0
0
0
0
Positioning of PHARMACIE DU GAREL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DU GAREL is estimated at
632 742 €
(range 440 631€ - 946 619€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
440k€632k€946k€
632 742 €Range: 440 631€ - 946 619€
NAF 5 année 2024
Valuation method used
Net Income Multiple
45 323 €
×
14.0x
=632 743 €
Range: 440 632€ - 946 619€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU GAREL with other companies in the same sector:
Frequently asked questions about PHARMACIE DU GAREL
What is the revenue of PHARMACIE DU GAREL ?
The revenue of PHARMACIE DU GAREL in 2018 is 1.1 M€.
Is PHARMACIE DU GAREL profitable?
Yes, PHARMACIE DU GAREL generated a net profit of 45 k€ in 2024.
Where is the headquarters of PHARMACIE DU GAREL ?
The headquarters of PHARMACIE DU GAREL is located in BRIGNAIS (69530), in the department Rhone.
Where to find the tax return of PHARMACIE DU GAREL ?
The tax return of PHARMACIE DU GAREL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU GAREL operate?
PHARMACIE DU GAREL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart